circASXL1-1 regulates BAP1 deubiquitinase activity in leukemia

• Shweta Pradip Jadhav,
• Nishi Kumari,
• Larry Ng,
• Pei Fang Tan,
• Nicole Shu Ling Yeo-Teh,
• Yufen Goh,
• Wee Nih Fam,
• Jia Qi Tng,
• Johann Shane Tian,
• Bryan T. H. Koh,
• Chan Ming Chun,
• Wilson Wang,
• Wee Joo Chng,
• Melissa Jane Fullwood,
• Ernesto Guccione,
• Neerja Karnani,
• Daniel G. Tenen,
• Sudhakar Jha

Affiliations

Shweta Pradip Jadhav

Cancer Science Institute of Singapore, National University of Singapore, Singapore

Nishi Kumari

Cancer Science Institute of Singapore, National University of Singapore, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Larry Ng

Cancer Science Institute of Singapore, National University of Singapore, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Pei Fang Tan

Singapore Institute for Clinical Sciences, A*STAR, Singapore

Nicole Shu Ling Yeo-Teh

Cancer Science Institute of Singapore, National University of Singapore, Singapore;National University of Singapore Graduate School for Integrative Sciences and Engineering, Singapore

Yufen Goh

Cancer Science Institute of Singapore, National University of Singapore, Singapore

Wee Nih Fam

Cancer Science Institute of Singapore, National University of Singapore, Singapore

Jia Qi Tng

Cancer Science Institute of Singapore, National University of Singapore, Singapore

Johann Shane Tian

Cancer Science Institute of Singapore, National University of Singapore, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Bryan T. H. Koh

Department of Orthopedic Surgery, National University Health Systems, Singapore

Chan Ming Chun

Department of Orthopedic Surgery, National University Health Systems, Singapore

Wilson Wang

Department of Orthopedic Surgery, National University of Singapore, Singapore

Wee Joo Chng

Cancer Science Institute of Singapore, National University of Singapore, Singapore;Department of Hematology-Oncology, National University Cancer Institute, Singapore

Melissa Jane Fullwood

Cancer Science Institute of Singapore, National University of Singapore, Singapore;School of Biological Sciences, Nanyang Technological Institute, Singapore;Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore

Ernesto Guccione

Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore;Tisch Cancer Institute, Department of Oncological Sciences and Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Neerja Karnani

Singapore Institute for Clinical Sciences, A*STAR, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Daniel G. Tenen

Cancer Science Institute of Singapore, National University of Singapore, Singapore;Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA

Sudhakar Jha

Cancer Science Institute of Singapore, National University of Singapore, Singapore;Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore